Mary Laird, MD, FAAD
Assistant Professor in DermatologyCards
About
Research
Publications
2023
Systemic Contact Dermatitis and Epicutaneous Allergic Contact Dermatitis to Benzyl Alcohol.
Laird ME, Watsky KL. Systemic Contact Dermatitis and Epicutaneous Allergic Contact Dermatitis to Benzyl Alcohol. Dermatitis 2023, 34: 355-356. PMID: 36287992, DOI: 10.1097/DER.0000000000000876.Peer-Reviewed Original Research
2022
Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
Choi R, Garritano J, Laird M, Johnston M, Tkachenko E, Damsky W, Little AJ, McNiff J, Girardi M, Nelson CA. Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept. JAAD Case Reports 2022, 29: 139-141. PMID: 36160836, PMCID: PMC9485430, DOI: 10.1016/j.jdcr.2022.09.009.Peer-Reviewed Case Reports and Technical Notes
2019
Conservative Treatment of Retronychia: A Retrospective Study of 25 Patients.
Laird ME, Lo Sicco KI, Rich P. Conservative Treatment of Retronychia: A Retrospective Study of 25 Patients. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [et Al.] 2019, 45: 614-616. PMID: 30346320, DOI: 10.1097/DSS.0000000000001649.Peer-Reviewed Original Research
2018
Concentric targetoid scaly plaques in a patient with severe rheumatoid arthritis.
Laird ME, Sukhdeo K, Ho A, Hoffmann RK, Meehan SA, Kim RH. Concentric targetoid scaly plaques in a patient with severe rheumatoid arthritis. International Journal Of Dermatology 2018, 57: 913-914. PMID: 29638000, DOI: 10.1111/ijd.13991.Peer-Reviewed Original ResearchRegression of pigmented lesions in a patient with metastatic melanoma treated with immunotherapy.
Schwager Z, Laird ME, Latkowski JA. Regression of pigmented lesions in a patient with metastatic melanoma treated with immunotherapy. JAAD Case Reports 2018, 4: 421-423. PMID: 29984269, PMCID: PMC6031483, DOI: 10.1016/j.jdcr.2017.10.019.Peer-Reviewed Original Research
2017
What's in a Name-Dermoscopy vs Dermatoscopy.
Berk-Krauss J, Laird ME. What's in a Name-Dermoscopy vs Dermatoscopy. JAMA Dermatology 2017, 153: 1235. PMID: 29238835, DOI: 10.1001/jamadermatol.2017.3905.Peer-Reviewed Original ResearchRole of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma
Fanok MH, Sun A, Fogli LK, Narendran V, Eckstein M, Kannan K, Dolgalev I, Lazaris C, Heguy A, Laird ME, Sundrud MS, Liu C, Kutok J, Lacruz RS, Latkowski JA, Aifantis I, Ødum N, Hymes KB, Goel S, Koralov SB. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. Journal Of Investigative Dermatology 2017, 138: 1116-1125. PMID: 29128259, PMCID: PMC5912980, DOI: 10.1016/j.jid.2017.10.028.Peer-Reviewed Original ResearchConceptsCutaneous T-cell lymphomaT-cell lymphomaHigh-throughput transcriptional profilingJAK/STATT cell receptor engagementT cellsGenetic perturbationsTranscriptome analysisTranscriptional profilingConditional geneDeep sequencingCytokine signalingTumor genomesMalignant T cellsCellular etiologyHeterogeneous landscapesReceptor engagementSmall animal modelsCommon variantsMycosis fungoidesKey cytokineAntigenic stimulationT lymphocytesLymphoma pathogenesisMouse modelHepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.
Wiznia LE, Laird ME, Franks AG. Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era. Journal Of The European Academy Of Dermatology And Venereology : JEADV 2017, 31: 1260-1270. PMID: 28252812, DOI: 10.1111/jdv.14186.Peer-Reviewed Original ResearchNovel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosum.
Laird ME, Tong LX, Lo Sicco KI, Kim RH, Meehan SA, Franks AG. Novel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosum. JAAD Case Reports 2017, 3: 228-229. PMID: 28443317, PMCID: PMC5394202, DOI: 10.1016/j.jdcr.2017.02.019.Peer-Reviewed Original ResearchDefining and Measuring the Scope of Atopic Dermatitis.
Laird M, Lo Sicco K. Defining and Measuring the Scope of Atopic Dermatitis. Advances In Experimental Medicine And Biology 2017, 1027: 93-104. PMID: 29063434, DOI: 10.1007/978-3-319-64804-0_9.Peer-Reviewed Original Research
Clinical Care
Overview
Mary T. Laird, MD, is a dermatologist who diagnoses and treats a variety of skin conditions. She has a particular interest in women’s health and dermatology, especially dermatology as it relates to pregnancy and lactation.
Dr. Laird emphasizes the importance of patient interaction and education in her practice. "The skin can really be a window into a person's overall health and has a huge impact on how people interact with the world,” she says. “My favorite part of my job is speaking with patients, understanding their goals, and finding the right treatment for them.”
As assistant professor of dermatology at Yale School of Medicine, Dr. Laird also enjoys working with and teaching residents and medical students.
Dr. Laird received her medical degree from New York University School of Medicine, completed her internship at Memorial Sloan Kettering Cancer Center, and her dermatology residency at Yale University.
Clinical Specialties
Dermatology
Fact Sheets
Birthmarks
Learn More on Yale MedicineSeborrheic Keratosis
Learn More on Yale MedicineRosacea
Learn More on Yale MedicineCutaneous T-cell Lymphoma
Learn More on Yale Medicine
Yale Medicine News
Get In Touch
Contacts
Email
Appointment Number
Clinic Fax Number
Mailing Address
Yale School of Medicine
15 York Street, PO Box 208059
New Haven , CT 06520
United States
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.